Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
VXF vs XLV: how they differ
VXF and XLV hold 0% of their weight in the same names, and XLV returned more over the year.
Vanguard Extended Market Index Fund and State Street(R) Health Care Select Sector SPDR(R) ETF.
What they hold in common
By the books each fund has filed, VXF and XLV hold 0% of their money in the same securities at the same weight.
| Only in VXF | Only in XLV |
|---|---|
| Space Exploration Technologies Corp 1.19% | Eli Lilly & Co 16.56% |
| Snowflake Inc 1.03% | Johnson & Johnson 10.67% |
| Bloom Energy Corp 0.93% | AbbVie Inc 7.76% |
| Cloudflare Inc 0.92% | UnitedHealth Group Inc 6.59% |
| Astera Labs Inc 0.76% | Merck & Co Inc 5.54% |
| Rocket Lab Corp 0.61% | Amgen Inc 3.41% |
| Cheniere Energy Inc 0.59% | Thermo Fisher Scientific Inc 3.25% |
| Ferguson Enterprises Inc 0.54% | Abbott Laboratories 2.76% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026.
| VXF Vanguard Extended Market Index Fund | XLV State Street(R) Health Care Select Sector SPDR(R) ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | Vanguard | State Street |
| What it is | Extended Market | Health care |
| Total return, 1 year | +14.1% | +20.4% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | −3.4 pts | +2.9 pts |
| Expense ratio | 0.05% | 0.08% |
| Already in the S&P 500 | 0.0% | 100.0% |
| Holdings | 3365 | 59 |
VXF in plain words
VXF is an index equity fund tracking the Extended Market. Over the year to Sep 11, 2026 it returned +14.1% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.05% a year. By its holdings filed for Jun 30, 2026, 0% of the fund by weight is stocks the S&P 500 also holds, across 3365 positions, with the top ten at 7.6%. It sat 5.1% below its high of Aug 14, 2026 on Sep 11, 2026.
XLV in plain words
XLV is an index equity fund tracking the Health care. Over the year to Sep 11, 2026 it returned +20.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.08% a year. By its holdings filed for Jun 30, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 59 positions, with the top ten at 61.7%. It sat 5.9% below its high of Aug 19, 2026 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, VXF or XLV?
- In the year to Sep 12, 2026, with distributions reinvested, VXF returned +14.1% and XLV returned +20.4%, so XLV returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, VXF or XLV?
- VXF charges 0.05% a year and XLV charges 0.08%, so VXF is cheaper. Fees come from each fund's prospectus.
- How much do VXF and XLV overlap with the S&P 500?
- By their latest filed holdings, 0% of VXF and 100% of XLV by weight is stocks the S&P 500 already holds. Between the two funds, 0% of their books are the same securities at the same weight.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, VXF against XLV, data as of Sep 12, 2026. https://etfiq.com/compare/any/VXF-XLV Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources